Taberner-Cortés, A.; Vinué, Á.; Herrero-Cervera, A.; Aguilar-Ballester, M.; Real, J.T.; Burks, D.J.; Martínez-Hervás, S.; González-Navarro, H.
Dapagliflozin Does Not Modulate Atherosclerosis in Mice with Insulin Resistance. Int. J. Mol. Sci. 2020, 21, 9216.
https://doi.org/10.3390/ijms21239216
AMA Style
Taberner-Cortés A, Vinué Á, Herrero-Cervera A, Aguilar-Ballester M, Real JT, Burks DJ, Martínez-Hervás S, González-Navarro H.
Dapagliflozin Does Not Modulate Atherosclerosis in Mice with Insulin Resistance. International Journal of Molecular Sciences. 2020; 21(23):9216.
https://doi.org/10.3390/ijms21239216
Chicago/Turabian Style
Taberner-Cortés, Alida, Ángela Vinué, Andrea Herrero-Cervera, María Aguilar-Ballester, José Tomás Real, Deborah Jane Burks, Sergio Martínez-Hervás, and Herminia González-Navarro.
2020. "Dapagliflozin Does Not Modulate Atherosclerosis in Mice with Insulin Resistance" International Journal of Molecular Sciences 21, no. 23: 9216.
https://doi.org/10.3390/ijms21239216
APA Style
Taberner-Cortés, A., Vinué, Á., Herrero-Cervera, A., Aguilar-Ballester, M., Real, J. T., Burks, D. J., Martínez-Hervás, S., & González-Navarro, H.
(2020). Dapagliflozin Does Not Modulate Atherosclerosis in Mice with Insulin Resistance. International Journal of Molecular Sciences, 21(23), 9216.
https://doi.org/10.3390/ijms21239216